XLV250502C144500
- 0.08
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
Goldman Sachs lowers the target for the S&P 500 Index, Bullish on the outlook for the Technology, Medical, and Financial Sectors.
Citi has significantly lowered its year-end target for the S&P 500 Index from the original 6,500 points to 5,800 points, while also reducing its EPS forecast from $270 to $255, and has particularly recommended four advantageous sectors: Information Technology, Communications Services, Medical Care, and Financial stocks.
India Proposes Zero-for-zero Tariff Deal on U.S. Auto Parts, Steel - Report
'Trump To Sign Order To Encourage Domestic Drug Manufacturing' - Washington Post
Oric Pharmaceuticals Announces Clinical Trial Collaboration And Supply Agreement With Johnson & Johnson To Evaluate ORIC-114 In Combination With Subcutaneous Amivantamab For The First-Line Treatment Of NSCLC Patients With EGFR Exon 20 Insertion Mutations
Schwab Trading Activity Index Retreats to Two-year Low the Same Month Tariffs Announced
10 Health Care Stocks Whale Activity In Today's Session
Merck & Co Unusual Options Activity
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
These Are the Sectors Best Liked Within Defensive and Cyclicals Groups – Morgan Stanley
Citi Cuts S&P Target and Highlights Tech, Healthcare, Financials and Other Segments
Teva, Alvotech Get FDA Nod for Johnson & Johnson Biosimilar
Sector Update: Health Care Stocks Decline Pre-Bell Monday
Leading And Lagging Sectors For May 5, 2025
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Investors Brace for Fed Decision
Johnson & Johnson Announces New Data From Phase 3 ASTRO Study Evaluating TREMFYA Subcutaneous Induction Therapy In Adults With Ulcerative Colitis
Notable Healthcare Headlines for the Week: Gilead, CVS Health, Sanofi in Focus
Healthcare Sector Flexes Earnings Muscle, but Top-line Cracks Show
UBS Maintains Buy on Eli Lilly, Lowers Price Target to $1050
Eli Lilly Analyst Ratings
Abbott Gains After Upcoming Baby Formula Case Thrown Out